AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 10, 2023

Primary Completion Date

August 31, 2024

Study Completion Date

December 31, 2029

Conditions
Gastric CancerImagePathology
Interventions
DRUG

Neoadjuvant Chemotherapy

Participants in this group are diagnosed with gastric cancer and are scheduled to undergo neoadjuvant chemotherapy as a part of their treatment regimen. The specific chemotherapy drugs, dosages, and schedules will be determined according to established clinical guidelines and the participant's specific condition.

Trial Locations (22)

Unknown

NOT_YET_RECRUITING

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

NOT_YET_RECRUITING

Peking Union Medical College Hospital, Beijing

RECRUITING

Peking University Cancer Hospital & Institute, Beijing

NOT_YET_RECRUITING

Peking University People's Hospital, Beijing

NOT_YET_RECRUITING

Xiangya Hospital of Central South University, Changsha

NOT_YET_RECRUITING

Fujian Cancer Hospital, Fuzhou

RECRUITING

Fujian Medical University Union Hospital, Fuzhou

NOT_YET_RECRUITING

Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou

NOT_YET_RECRUITING

First Affiliated Hospital, Sun Yat-Sen University, Guangzhou

NOT_YET_RECRUITING

Nanfang Hospital of Southern Medical University, Guangzhou

RECRUITING

Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou

RECRUITING

Yunnan Cancer Hospital, Kunming

NOT_YET_RECRUITING

Cancer Hospital of Guangxi Medical University, Nanning

NOT_YET_RECRUITING

The Affiliated Hospital of Qingdao University, Qingdao

NOT_YET_RECRUITING

Ruijin Hospital, Shanghai

NOT_YET_RECRUITING

First Hospital of China Medical University, Shenyang

NOT_YET_RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

NOT_YET_RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

RECRUITING

Henan Cancer Hospital, Zhengzhou

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

RECRUITING

Zhenjiang First People's Hospital, Zhenjiang

RECRUITING

San Raffaele University Hospital, Italy, Milan

Sponsors
All Listed Sponsors
collaborator

Peking University Cancer Hospital & Institute

OTHER

collaborator

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

collaborator

Yunnan Cancer Hospital

OTHER

collaborator

Henan Cancer Hospital

OTHER_GOV

collaborator

Zhenjiang First People's Hospital

OTHER

collaborator

First Hospital of China Medical University

OTHER

collaborator

Cancer Hospital of Guangxi Medical University

OTHER

collaborator

Peking University People's Hospital

OTHER

collaborator

Tianjin Medical University Cancer Institute and Hospital

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

Nanfang Hospital, Southern Medical University

OTHER

collaborator

The Affiliated Hospital of Qingdao University

OTHER

collaborator

Ruijin Hospital

OTHER

collaborator

Sixth Affiliated Hospital, Sun Yat-sen University

OTHER

collaborator

Peking Union Medical College Hospital

OTHER

collaborator

Xiangya Hospital of Central South University

OTHER

collaborator

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

OTHER

collaborator

The First Affiliated Hospital of Soochow University

OTHER

collaborator

First Affiliated Hospital, Sun Yat-Sen University

OTHER

collaborator

Fujian Medical University Union Hospital

OTHER

collaborator

Fujian Cancer Hospital

OTHER_GOV

collaborator

San Raffaele University Hospital, Italy

OTHER

lead

Chinese Academy of Sciences

OTHER_GOV

NCT06035250 - AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy | Biotech Hunter | Biotech Hunter